Enclave Advisors LLC Merck & Co., Inc. Transaction History
Enclave Advisors LLC
- $590 Billion
- Q3 2024
A detailed history of Enclave Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Enclave Advisors LLC holds 2,105 shares of MRK stock, worth $207,047. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,105Holding current value
$207,047% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,803Shares Held
1.9BCall Options Held
13.5MPut Options Held
11.1M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.46 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.82 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...